Clinical Trial Update: Study of of Oxygen Nebulized Inhalation EGCG in Cancer Patients With New Coronary Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 trial assessing oxygen-nebulized inhalation of epigallocatechin gallate (EGCG) in cancer patients with interstitial pneumonia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Interstitial Pneumonia

Drugs mentioned

• Oxygen nebulized EGCG inhalation (epigallocatechin gallate)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Pneumonia, Interstitial, Cancer Patients | Phase 2 | Status: COMPLETED